What is QNRX's earnings growth forecast for 2025-2025?
(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Quoin Pharmaceuticals's earnings in 2025 is -$12,169,276.
In 2025, QNRX is forecast to generate -$526,379,673 in earnings, with the lowest earnings forecast at -$526,379,673 and the highest earnings forecast at -$526,379,673.
What is QNRX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: QNRX) forecast ROE is -20,631.36%, which is considered weak.
What is QNRX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. In 2025, QNRX's EPS is forecast to hit -$25.57 (min: -$25.57, max: -$25.57).
What is QNRX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: QNRX) forecast ROA is -5,906.02%, which is lower than the forecast US Biotechnology industry average of -3.97%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.